Shire Hits Allergan With Antitrust Suit Over Dry Eye Drugs
Allergan Inc. has engaged in anti-competitive conduct in an effort to block Medicare Part D beneficiaries from purchasing Shire U.S. Inc.'s competing treatment for dry eye disease, a suit filed Monday...To view the full article, register now.
Already a subscriber? Click here to view full article